Molecular Medicine · 2011 · 46 citations · 35 references
Life SciencesDermatologyImmunologyCell SignalingInflammationInnate ImmunityInflammatory Cell ResponsesInflammatory SignalingInnate Immune ResponseSkin Barrier FunctionSkin InfectionsWound InflammationAdvanced Glycation End ProductsCutaneous Immune ResponseDefensin ExpressionDefensin FamilyGlucose ExposureInnate Immunity PathwaysKeratinocyte ActivationPathogenic Effects
Diabetes mellitus is characterized by elevated plasma glucose and increased rates of skin infections. Altered immune responses have been suggested to contribute to this prevalent complication, which involves microbial invasion. In this study we explored the effects of a high-glucose environment on the innate immunity of keratinocytes by focusing on β defensin-3 (BD3) using in vivo and in vitro models. Our results demonstrated that the perilesional skins of diabetic rats failed to show enhanced BD3 expression after wounding. In addition, high-glucose treatment reduced human BD3 (hBD3) expression of cultured human keratinocytes. This pathogenic process involved inhibition of p38MAPK signaling, an event that resulted from increased formation of advanced glycation end products. On the other hand, toll-like receptor-2 expression and function of cultured keratinocytes were not significantly affected by high-glucose treatment. In summary, high-glucose conditions inhibited the BD3 expression of epidermal keratinocytes, which in turn contributed to the frequent occurrences of infection associated with diabetic wounding.
35
Impaired Leucocyte Functions in Diabetic Patients
M. Delamaire, D Maugendre, María de Lourdes Moreno et al. · Diabetic Medicine · 1997 · 1.1K citations
Harry M. Lander, James M. Tauras, Jason S. Ogiste et al. · Journal of Biological Chemistry · 1997 · 812 citations · Full text
Life Sciences, Physiology, Aging +16
Nicolas W.J. Schröder, Siegfried Morath, Christian Alexander et al. · Journal of Biological Chemistry · 2003 · 636 citations · Full text